{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0975798/OMIM:620940","label":"Methylmalonic aciduria and homocystinuria, cblL type","mondoId":"MONDO:0975798","onsetQualifier":null,"recordKeys":["26c6e52188e660d9fcfeb005b8fb6f0f696613d84b30e55201db3f832266cc97","2c5df3cb1a5f695644a155f5a2212595203fbe8eebaad09e41963c53953e9a2f","a014398390446dab699593a03cf3e2587f3684b211575fc4e823f91d64620b11","a140cf7dbaf06a288f99687219c5cb07d6be18bf1021ac68d9b8989b144aa6e5","b075e21294addaaacda4bc131c8831a2022e68b4fc1a309a168ebd27521a0e56","b305ee070cc6028d694a19518981f1f4a7202ea0f158606497130f91ca73a1e8","b6b06fc00a7944603a34faa621c1820a237854059ac3e41cc5767addd0c31b9c","bbc7e22bc68389beb575fed9d222bf837cc8254fdc0c4ef53815b4bee3cce403","bbf9849607f9b6d91b2cf6d1090fd7e75bc3f6152fd107ed27128551a6f38df8","c44200b226786964909fbcf91ae8453ac0b95d2aba7c69a69e52e5fab0677533","d7d8b21efa331b4179be09783100dd4fe5d8798d9bab870b0f7e0f0f4b184a3c"],"recordQualifiers":{},"scopeLabel":"OMIM:620940","sourceIds":["OMIM:620940"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0975798/OMIM:620940"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":0,"orphanet":0,"published":11}},"features":[{"hpoId":"HP:0010901","label":"Abnormal circulating methionine concentration","primary":false},{"hpoId":"HP:0001627","label":"Abnormal heart morphology","primary":false},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":false},{"hpoId":"HP:0000565","label":"Esotropia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002156","label":"Homocystinuria","primary":false},{"hpoId":"HP:0000540","label":"Hypermetropia","primary":false},{"hpoId":"HP:0012120","label":"Methylmalonic aciduria","primary":false},{"hpoId":"HP:0032794","label":"Myoclonic seizure","primary":false},{"hpoId":"HP:0002187","label":"Profound intellectual disability","primary":false},{"hpoId":"HP:0002445","label":"Tetraplegia","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0975798","records":[{"frequencyKind":"count","key":"26c6e52188e660d9fcfeb005b8fb6f0f696613d84b30e55201db3f832266cc97","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002445","is_excluded":false,"label":"Tetraplegia","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2c5df3cb1a5f695644a155f5a2212595203fbe8eebaad09e41963c53953e9a2f","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000565","is_excluded":false,"label":"Esotropia","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a014398390446dab699593a03cf3e2587f3684b211575fc4e823f91d64620b11","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a140cf7dbaf06a288f99687219c5cb07d6be18bf1021ac68d9b8989b144aa6e5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0010901","is_excluded":true,"label":"Abnormal circulating methionine concentration","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b075e21294addaaacda4bc131c8831a2022e68b4fc1a309a168ebd27521a0e56","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0001627","is_excluded":true,"label":"Abnormal heart morphology","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b305ee070cc6028d694a19518981f1f4a7202ea0f158606497130f91ca73a1e8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b6b06fc00a7944603a34faa621c1820a237854059ac3e41cc5767addd0c31b9c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0032794","is_excluded":false,"label":"Myoclonic seizure","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bbc7e22bc68389beb575fed9d222bf837cc8254fdc0c4ef53815b4bee3cce403","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0002156","is_excluded":true,"label":"Homocystinuria","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bbf9849607f9b6d91b2cf6d1090fd7e75bc3f6152fd107ed27128551a6f38df8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012120","is_excluded":false,"label":"Methylmalonic aciduria","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c44200b226786964909fbcf91ae8453ac0b95d2aba7c69a69e52e5fab0677533","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002187","is_excluded":false,"label":"Profound intellectual disability","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d7d8b21efa331b4179be09783100dd4fe5d8798d9bab870b0f7e0f0f4b184a3c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:620940","disease_name":"Methylmalonic aciduria and homocystinuria, cblL type","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000540","is_excluded":false,"label":"Hypermetropia","onset_id":null,"reference":"PMID:28449119","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"methylmalonic-aciduria-and-homocystinuria-cb1l-type","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"methylmalonic aciduria and homocystinuria, cb1L type"},"schemaVersion":1}